Nephrology expert duo Drs. Brad Rovin and Shikha Wadhwani team up to discuss recent insights and considerations when managing patients with IgA Nephropathy. Listen in to hear about their patient encounters, insightful strategies around how they manage IgAN, and how emerging new data may impact clinical considerations moving forward.1,2
References: 1. Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-Term Outcomes in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 2023 Apr 13;10.2215/CJN.0000000000000135. 2. Selvaskandan H, Barratt J, Cheung CK. Novel Treatment Paradigms: Primary IgA Nephropathy. Kidney International Reports. 2024 Feb 1;9(2):203–13.